Andrew J. Last's Net Worth
$7.81 Million
Who is Andrew J. Last?
Andrew J. Last has an estimated net worth of $7.81 Million. This is based on reported shares across multiple companies, which include BIO-RAD LABORATORIES, INC., INTREXON CORP, Oncocyte Corp, and AFFYMETRIX INC.
SEC CIK
Andrew J. Last's CIK is 0001485088
Past Insider Trading and Trends
2021 was Andrew J. Last's most active year for acquiring shares with 9 total transactions. Andrew J. Last's most active month to acquire stocks was the month of August. 2016 was Andrew J. Last's most active year for disposing of shares, totalling 14 transactions. Andrew J. Last's most active month to dispose stocks was the month of August. 2021 saw Andrew J. Last paying a total of $619,459.00 for 77,952 shares, this is the most they've acquired in one year. In 2015 Andrew J. Last cashed out on 239,114 shares for a total of $1,627,127.32, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIO-RAD LABORATORIES, INC. (BIO) Snapshot price: $329.75
EVP, Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$314.59 | -$92,095.20 | 7.56K |
Sep 6
| |||
Form 4
| +31.28% | 1.8K |
$337.32 | -$625,391.28 | 7.56K |
Sep 1 - Sep 2
| |||
Form 4
| +12.67% | 643 |
$277.11 | -$98,928.27 | 5.72K |
Apr 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
| +32.84% | 1.25K |
$394.60 | -$456,552.20 | 5.04K |
Sep 1 - Sep 2
| |||
Form 4
| +21.01% | 654 |
$450.79 | -$155,973.34 | 3.77K |
Apr 29
| |||
Form 4
| +17.27% | 454 |
$478.32 | -$214,287.36 | 3.08K |
Sep 2
| |||
Form 4
| +13.81% | 319 |
$486.25 | -$152,682.50 | 2.63K |
Sep 1
| |||
Form 4
| +29.99% | 529 |
$512.06 | -$241,180.26 | 2.29K |
Apr 29
| |||
Form 4
| +35.42% | 454 |
$557.33 | -$1,397,668.02 | 1.74K |
Sep 1 - Sep 2
| |||
Form 4
| +72.75% | 534 |
$640.73 | -$298,580.18 | 1.27K |
Apr 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 2
| |||
Form 4
| +2,517.66% | 654 |
$436.27 | -$150,949.42 | 679.98 |
Apr 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
INTREXON CORP (PGEN) Snapshot price: $0.9622
Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +100.00% | 2K |
$12.10 | $24,200.00 | 4K |
Nov 13
| |||
Form 4
|
∞
| 2K |
$19.99 | $39,980.00 | 2K |
Aug 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Oncocyte Corp (OCX) Snapshot price: $2.89
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
| +28.50% | 20K |
—
|
—
| 90.17K |
Jun 23
| |||
Form 4
| +39.86% | 20K |
$0.87 | $17,400.00 | 70.17K |
Aug 17
| |||
Form 4
| +24.89% | 10K |
—
|
—
| 50.17K |
Aug 15
| |||
Form 4
| +33.15% | 10K |
—
|
—
| 40.17K |
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
| +30.17% | 6.99K |
$3.00 | $20,979.00 | 30.17K |
Jun 11
| |||
Form 4
| +231.43% | 16.18K |
—
|
—
| 23.18K |
Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 30
| |||
Form 4
|
∞
| 6.99K |
—
|
—
| 6.99K |
Jul 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
AFFYMETRIX INC No price found
EVP, Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -223.55K |
—
|
—
|
0
|
Mar 31
| |||
Form 4
| -0.42% | -940.00 |
$14.06 | -$13,216.40 | 223.55K |
Feb 25
| |||
Form 4
| +7.02% | 29.55K |
$13.98 | -$87,668.58 | 450.57K |
Feb 18 - Feb 19
| |||
Form 4
| -6.01% | -12.47K |
$14.09 | -$175,660.03 | 194.94K |
Feb 13 - Feb 14
| |||
Form 4
| +21.92% | 37.3K |
—
|
—
| 207.41K |
Feb 8
| |||
Form 4
|
—
|
0
|
$8.95 | -$846,400.00 | 170.11K |
Scheduled
|
Mar 25
| ||
Form 4
| -3.21% | -5.64K |
$11.64 | -$65,626.32 | 170.11K |
Feb 25
| |||
Form 4
| +10.71% | 17K |
—
|
—
| 175.75K |
Feb 19
| |||
Form 4
| -7.82% | -13.48K |
$11.47 | -$154,601.00 | 158.75K |
Feb 13 - Feb 17
| |||
Form 4
| +30.25% | 40K |
—
|
—
| 172.23K |
Feb 2
| |||
Form 4
| -1.06% | -1.41K |
$8.73 | -$12,309.30 | 132.23K |
Aug 19
| |||
Form 4
| -3.99% | -5.55K |
$7.47 | -$41,488.38 | 133.64K |
Feb 25
| |||
Form 4
| -3.04% | -4.37K |
$7.28 | -$31,806.32 | 139.19K |
Feb 14 - Feb 17
| |||
Form 4
| +62.11% | 55K |
—
|
—
| 143.56K |
Feb 11 - Feb 13
| |||
Form 4
| -2.08% | -1.88K |
$8.33 | -$15,660.40 | 88.56K |
Dec 17
| |||
Form 4
| -1.54% | -1.41K |
$4.95 | -$6,979.50 | 90.44K |
Aug 19
| |||
Form 4
| +46.47% | 28.9K |
$3.85 | -$4,223.45 | 91.1K |
Feb 14 - Feb 17
| |||
Form 4
| -2.93% | -1.83K |
$3.32 | -$6,092.20 | 60.7K |
Dec 17
| |||
Form 4
| -2.15% | -1.38K |
$3.86 | -$5,311.36 | 62.53K |
Aug 19
| |||
Form 4
| +18.55% | 10K |
$4.06 | $40,600.00 | 63.91K |
Aug 3
| |||
Form 4
| -1.91% | -1.05K |
$4.61 | -$4,831.28 | 53.91K |
Feb 17
| |||
Form 4
| -3.23% | -1.83K |
$3.80 | -$6,969.20 | 54.95K |
Dec 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 17
| |||
Form 4
| -2.37% | -1.38K |
$4.53 | -$6,233.28 | 56.79K |
Aug 19
| |||
Form 4
| +9.40% | 5K |
$4.16 | $20,800.00 | 58.16K |
Aug 8
| |||
Form 4
| +23.17% | 10K |
$5.31 | $53,100.00 | 53.16K |
Feb 17
| |||
Form 4
| -4.08% | -1.83K |
$5.08 | -$9,321.80 | 43.16K |
Dec 17
| |||
Form 4
| +28.57% | 10K |
$4.07 | $40,650.00 | 45K |
Aug 20
| |||
Form 4
| +75.00% | 15K |
$4.22 | $63,300.00 | 35K |
Aug 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |